Prostate Cancer

1.

Bill-Axelson A, Holmberg L, Ruutu M, et al.
Radical prostatectomy versus watchful waiting in early prostate cancer.
NEW ENGLAND JOURNAL OF MEDICINE 352 (19): 1977-1984 MAY 12 2005 

317

2.

Tomlins SA, Rhodes DR, Perner S, et al.
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
SCIENCE 310 (5748): 644-648 OCT 28 2005

254

3.

Aus G, Abbou CC, Bolla M, et al.
EAU guidelines on prostate cancer.
EUROPEAN UROLOGY 48 (4): 546-551 OCT 2005 

207

4.

Albertsen PC, Hanley JA, Fine J
20-year outcomes following conservative management of clinically localized prostate cancer.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 293 (17): 2095-2101 MAY 4 2005

175

5.

Collins AT, Berry PA, Hyde C, et al.
Prospective identification of tumorigenic prostate cancer stem cells.
CANCER RESEARCH 65 (23): 10946-10951 DEC 1 2005
JOURNAL OF BIOLOGICAL CHEMISTRY 280 (20): 19911-19924 MAY 20 2005

171

6.

Freedland SJ, Humphreys EB, Mangold LA, et al.
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 294 (4): 433-439 JUL 27 2005 

150

7.

Semmes OJ, Feng Z, Adam BL, et al.
Evaluation of serum protein profiling by surface-enhanced laser esorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
LINICAL CHEMISTRY 51 (1): 102-112 JAN 2005

146

8.

Shahinian VB, Kuo Y, Freeman JL, et al.
Risk of fracture after androgen deprivation for prostate cancer.
NEW ENGLAND JOURNAL OF MEDICINE 352 (2): 154-164 JAN 13 2005

139

9.

Seligson DB, Horvath S, Shi T, et al.
Global histone modification patterns predict risk of prostate cancer recurrence.
NATURE 435 (7046): 1262-1266 JUN 30 2005

129

10.

Shah RB, Mehra R, Chinnaiyan AM, et al.
Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program.
CANCER RESEARCH 64 (24): 9209-9216 DEC 15 2004 

122